Mechanism of Action
The drug belongs to the thiazide diuretic class. Its primary target is the epithelium of the early distal convoluted tubule of the nephron.
Hydrochlorothiazide inhibits the sodium-chloride symporter ($Na^+-Cl^-$ cotransporter). By blocking sodium reabsorption in the renal tubules, the drug leaves sodium within the tubular lumen. Through an osmotic gradient, sodium pulls water along with it, leading to increased diuresis and the elimination of excess fluid from the body.
Pharmacokinetics and Dosing
The drug is well absorbed from the gastrointestinal tract following oral administration.
- Onset of action: The diuretic effect develops fairly rapidly — within 30–60 minutes after ingestion.
- Peak effect: Maximum action is recorded at 2 hours.
- Duration: The effect persists for 8 to 12 hours.
Dosing guidelines: The medication is available in 25 mg tablets. It is administered orally, after meals. The dosage regimen is once daily in the morning, ranging from 1 to 4 tablets depending on the clinical situation. Morning administration is supported by pharmacokinetics: the 12-hour duration of action will conclude by evening, avoiding disruption of the patient's nocturnal sleep.
Indications for Use
Hydrochlorothiazide has a broad spectrum of clinical applications. It is prescribed for the following conditions:
- Hypertension: Serves as a first-line drug. Highly effective for the systematic treatment of essential hypertension and can be used as monotherapy.
- Edematous states: A standard indication for the removal of excess fluid.
- Nephrogenic diabetes insipidus: Used due to its paradoxical antidiuretic effect (it reduces urine output, although the exact mechanism remains not fully understood).
- Nephrolithiasis (kidney stones): The drug affects calcium metabolism. It reduces $Ca^{2+}$ ion excretion in the urine, preventing the formation of insoluble calcium salts within the renal filtrate, which serves as excellent prophylaxis for stone formation.
Side Effects
The adverse effect profile of hydrochlorothiazide requires careful patient monitoring. The main side effects are divided into three groups:
- Electrolyte disturbances: The drug actively promotes ion excretion, leading to hypokalemia and hypomagnesemia.
- Metabolic disturbances: It can cause uric acid retention in the body, provoking hyperuricemia. Elevated blood glucose levels (hyperglycemia) may also occur during therapy.
- General and dyspeptic disorders: Patients may complain of nausea and generalized weakness.
Role in Combination Therapy
In clinical practice, hydrochlorothiazide is very frequently utilized within fixed-dose combination antihypertensive formulations. This provides synergistic efficacy and dosing convenience.
Classic examples of combinations (primarily based on the sympatholytic agent reserpine):
- Adelphane-Esidrex: Triple combination (Reserpine + vasodilator dihydralazine + hydrochlorothiazide 10 mg).
- Adelphane-Esidrex-K and Triresid K: Quadruple combinations. Potassium chloride (at a dose of 0.6 g) is added to the previous formulation specifically to correct electrolyte balance and prevent thiazide-induced hypokalemia.
- Crystepin: An alternative combination (Reserpine + ergot alkaloid dihydroergotoxine + the thiazide-like diuretic clopamide).
Additionally, in diuretic therapy management, drug interactions must be considered. For example, to achieve rapid fluid removal, a loop diuretic (furosemide) may be administered alongside a potassium-sparing diuretic (spironolactone). As the slower effect of spironolactone takes hold, the loop diuretic is discontinued, and maintenance therapy may be continued with thiazides.